Before you sell to, join or invest in Darmiyan
MentionFox check on Darmiyan: only 1 source on file so far (checked 10 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/yc-darmiyan
Check Darmiyan before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Novel quantitative virtual microscopy for early detection of Alzheimer's disease from non-invasive MRI.
Darmiyan is a Y Combinator company in the Summer 2017 batch. Its directory entry describes it as: Early detection of Alzheimer's disease. The founders listed are Padideh Kamali-Zare (Founder), Kaveh Vejdani (Founder/Chief Medical and Technology Officer) (Y Combinator directory entry, April 27, 2017).
Sell to companies like Darmiyan? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2017-04-27 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Darmiyan.
Free to see. No signup.
More on Darmiyan and the records around it.
Same batch, Healthcare first.
Get an email when Darmiyan changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Darmiyan raises, hires or launches. No email unless you switch it on.
Watch Darmiyan →Get the full cited report on Darmiyan
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Darmiyan: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Novel quantitative virtual microscopy for early detection of Alzheimer's disease from non-invasive MRI.
Checked away from the directory entry. Neither line below comes from the company's Y Combinator page.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Counted only where a thread links to this company's own site, announces it by name on that forum, or names it beside its own Y Combinator batch. A thread whose title merely carries the words is not counted — a name is not an identifier. Hacker News is not us, and nothing above is our opinion of the company.
I'm Padideh — brain enthusiast, data driven, and one of the brains behind Darmiyan. After my Ph.D. in Biological Physics from KTH (Sweden) and postdoc in computational neuroscience at NYU (New York), I dove headfirst into the startup world to tackle a cause close to my heart: Alzheimer's. I've been on a mission to outsmart this disease since my grandmother's diagnosis. BrainSee is our first product that catches Alzheimer's early and give people a fighting chance.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Darmiyan: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Darmiyan covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist DarmiyanYou get an alert in MentionFox the next time this company shows up.
If you're behind Darmiyan: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry, from the company's own site, read directly on 2026-09-27 (darmiyan.com), and from Hacker News, where 1 thread met the matching rule stated beside the count.
Each opens in a new tab, filled in for Darmiyan. With no account yet, you sign up free and land on the result.
Healthcare and health tech startups Medical device and diagnostics startups
Share the news. Sharing needs no account.
https://mentionfox.com/funding/yc-darmiyan